[The 7th international congress on spondyloarthropathy: Gent, October 2010].
At the Spondyloarthropathy (SpA) Congress 2010 new results were presented on the pathophysiology, imaging and therapy of this disease. With a better understanding in particular of the bone biology, the causes of the disease-specific alterations in bone could be explained in the future so that new therapy options can be developed. Magnetic resonance imaging is a milestone for a better understanding of the pathophysiology of SpA. Against the background of the pressure of increasing costs in the healthcare system and cost-intensive biologics it was discussed how well the therapeutic response to TNFα antagonists can be predicted. In connection with this it was critically commented that in the clinical routine time limited attempts at therapy in order to decide how the therapy should be continued depending on the response would be more useful than to make a strict selection of patients based on predictors.